EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A stress granule-associated RNA-binding protein FAM120A drives cisplatin resistance in non-small cell lung cancer

Shunsaku Hayai, Miho M Suzuki, Kenta Iijima, Keiko Shinjo iD, Yoshiteru Murofushi, Jingqi Xie iD, Tatsunori Nishimura, Makoto Ishii, Yutaka Kondo

The Journal of Biochemistry · 11.02.2026 · 179 (2) · 127-135

DOI: 10.1093/jb/mvaf074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Biochemistry, online erschienen am 15.12.2025. Verfasst von Shunsaku Hayai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Biology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation; and performed as research programs of the Grant-in-Aid for Scientific Research, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin-based chemotherapy is a standard treatment for non-small cell lung cancer (NSCLC), but drug resistance poses a major clinical challenge. Stress-adaptive mechanisms, such as stress granule (SG) formation, are increasingly recognized alternative pathways that facilitate cancer cell survival. Here, we identify the RNA-binding protein, family with sequence similarity 120A (FAM120A), as an SG-associated factor that drives cisplatin resistance in NSCLC. FAM120A expression was markedly elevated in cisplatin-resistant NSCLC cell lines and clinical tumor specimens and was essential for SG formation and cell survival following cisplatin-induced stress. We found that the intrinsically disordered RNA-binding domain of FAM120A is essential for its incorporation into SGs and for its cytoprotective function. Using enhanced cross-linking immunoprecipitation sequencing data and RNA immunoprecipitation-qPCR, we identified the long noncoding RNA, metastasis-associated lung adenocarcinoma transcript 1 as a key FAM120A interacting partner. MALAT1 levels were reduced upon FAM120A depletion, and overexpression of MALAT1 was sufficient to restore cisplatin resistance in these cells. These findings suggest that MALAT1 is an RNA species that is stabilized by FAM120A and involved in the cellular response to chemotherapy. Targeting this regulatory mechanism may offer new therapeutic strategies to overcome cisplatin resistance in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug Resistance, NeoplasmCarcinoma, Non-Small-Cell LungLung NeoplasmsRNA-Binding ProteinsStress GranulesAntineoplastic AgentsHumansRNA, Long NoncodingCell Line, Tumor

Stichwörter der Autor:innen

FAM120AMALAT1cisplatin resistancenon-small cell lung cancerstress granule

Substanzen

CisplatinRNA-Binding ProteinsAntineoplastic AgentsRNA, Long Noncoding

Autor:innen und Institutionen

  • Division of Cancer Biology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.
  • Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.
  • Laboratory Animal Facilities and Services, Institute of Photonics Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192 Shizuoka, Japan.
  • Institute for Glyco-core Research (iGCORE), Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8601, Japan.
  • Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8601, Japan.

ORCID-Profile: Keiko Shinjo, Jingqi Xie

Förderung

  • Japan Society for the Promotion of Science
  • Takeda Science Foundation; and performed as research programs of the Grant-in-Aid for Scientific Research
  • Japan Agency for Medical Research and Development

Zitieren

APA

Hayai, S., Suzuki, M. M., Iijima, K., Shinjo, K., Murofushi, Y., Xie, J., Nishimura, T., Ishii, M., & Kondo, Y. (2026). A stress granule-associated RNA-binding protein FAM120A drives cisplatin resistance in non-small cell lung cancer. The Journal of Biochemistry, 179(2), 127-135. https://doi.org/10.1093/jb/mvaf074

Vancouver

Hayai S, Suzuki MM, Iijima K, Shinjo K, Murofushi Y, Xie J, et al. A stress granule-associated RNA-binding protein FAM120A drives cisplatin resistance in non-small cell lung cancer. The Journal of Biochemistry. 2026;179(2):127-135. doi:10.1093/jb/mvaf074

BibTeX
@article{Hayai2026,
  author = {Hayai, Shunsaku and Suzuki, Miho M and Iijima, Kenta and Shinjo, Keiko and Murofushi, Yoshiteru and Xie, Jingqi and Nishimura, Tatsunori and Ishii, Makoto and Kondo, Yutaka},
  title = {A stress granule-associated RNA-binding protein FAM120A drives cisplatin resistance in non-small cell lung cancer},
  journal = {The Journal of Biochemistry},
  year = {2026},
  volume = {179},
  number = {2},
  pages = {127--135},
  doi = {10.1093/jb/mvaf074}
}
Kostenlos starten →